Supreme Court: Amalgamating Company Loss Cannot be Set Off Against Amalgamated Income  ||  Supreme Court: Hostile Witness Deposition Admissible to the Extent it is Found Credible and Reliable  ||  SC Upholds Penalty on Bank For Delay in Cheque Presentation under Consumer Protection Act  ||  Karnataka High Court Orders Strict Statewide Implementation of Menstrual Leave Policy  ||  Delhi HC: Emergency Arbitrator Awards are Not Binding on Indian Courts in Interim Relief Proceedings  ||  Del HC Imposes ?10L Fine on Parle Agro For Non-Disclosure of Sales Revenue in Pepsico Trademark Case  ||  Supreme Court: Spouse Cannot Withdraw Consent for Mutual Divorce After Settlement Agreement  ||  Supreme Court Suspends PC Act Sentence of Former Minister Anosh Ekka, Flags Overlapping CBI Cases  ||  Supreme Court: Magistrate’s Probe Order Can’t be Quashed on Accused’s Defence  ||  Delhi High Court: No Adverse Inference if Handwriting Sample Refused Without Section 73 Disclosure    

Delhi HC Issues Notice in PIL Seeking Selling of Remdesivir by All Pharma Firms in Domestic Market - (04 May 2021)

CIVIL

Delhi High Court has issued notice to the Centre and various pharma majors asking them to respond to a Public Interest Litigation seeking that all drug firms involved in the making Remdesivir be allowed to sell it in the domestic market. The Court has issued the notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus, and Cadila, seeking their stand on the issue.

Tags : DELHI HIGH COURT   SELLING OF REMDESIVIR  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved